These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 39164192)

  • 1. Exploring the molecular mechanisms and therapeutic potential of SMAD4 in colorectal cancer.
    Shan H; Tian G; Zhang Y; Qiu Z
    Cancer Biol Ther; 2024 Dec; 25(1):2392341. PubMed ID: 39164192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimetastatic role of Smad4 signaling in colorectal cancer.
    Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
    Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the impact of SMAD2 and SMAD4 downregulation in colorectal cancer and their correlation with immune markers, prognosis, and drug resistance and sensitivity.
    Amani MS; Peymani M
    Mol Biol Rep; 2024 Jul; 51(1):831. PubMed ID: 39037563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.
    Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Tumour Biol; 2012 Aug; 33(4):1005-14. PubMed ID: 22278155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
    Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
    World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMAD4--molecular gladiator of the TGF-beta signaling is trampled upon by mutational insufficiency in colorectal carcinoma of Kashmiri population: an analysis with relation to KRAS proto-oncogene.
    Sameer AS; Chowdri NA; Syeed N; Banday MZ; Shah ZA; Siddiqi MA
    BMC Cancer; 2010 Jun; 10():300. PubMed ID: 20565773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMAD7 and SMAD4 expression in colorectal cancer progression and therapy response.
    Rosic J; Dragicevic S; Miladinov M; Despotovic J; Bogdanovic A; Krivokapic Z; Nikolic A
    Exp Mol Pathol; 2021 Dec; 123():104714. PubMed ID: 34717960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer.
    Ai X; Wu Y; Zhang W; Zhang Z; Jin G; Zhao J; Yu J; Lin Y; Zhang W; Liang H; Datta PK; Zhang M; Zhang B; Chen X
    Cancer Biol Ther; 2013 Nov; 14(11):1059-67. PubMed ID: 24025354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment.
    Itatani Y; Kawada K; Sakai Y
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary Study of the Role F-Box Protein 32 (FBXO32) in Colorectal Neoplasms Through the Transforming Growth Factor beta (TGF-β)/Smad4 Signalling Pathway.
    Yuan X; Zhang Z; Jiang K; Wang X; Li Y
    Med Sci Monit; 2018 Feb; 24():1080-1088. PubMed ID: 29465067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of TGF-β Signaling Regulatory MicroRNAs in the Pathogenesis of Colorectal Cancer.
    Moradi-Marjaneh R; Khazaei M; Ferns GA; Aghaee-Bakhtiari SH
    Curr Pharm Des; 2018; 24(39):4611-4618. PubMed ID: 30636580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
    Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
    Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMAD4 mutations do not preclude epithelial-mesenchymal transition in colorectal cancer.
    Frey P; Devisme A; Rose K; Schrempp M; Freihen V; Andrieux G; Boerries M; Hecht A
    Oncogene; 2022 Feb; 41(6):824-837. PubMed ID: 34857888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice with dysfunctional TGF-β signaling develop altered intestinal microbiome and colorectal cancer resistant to 5FU.
    Wang Z; Hopson LM; Singleton SS; Yang X; Jogunoori W; Mazumder R; Obias V; Lin P; Nguyen BN; Yao M; Miller L; White J; Rao S; Mishra L
    Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166179. PubMed ID: 34082069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
    Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
    Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathway.
    Ma C; Liu M; Feng W; Rao H; Zhang W; Liu C; Xu Y; Wang Z; Teng Y; Yang X; Ni L; Xu J; Gao WQ; Lu B; Li L
    Clin Transl Med; 2023 Nov; 13(11):e1475. PubMed ID: 37962020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMAD4/DPC4 expression and prognosis in human colorectal cancer.
    Isaksson-Mettävainio M; Palmqvist R; Forssell J; Stenling R; Oberg A
    Anticancer Res; 2006; 26(1B):507-10. PubMed ID: 16739311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRMT5 methylating SMAD4 activates TGF-β signaling and promotes colorectal cancer metastasis.
    Liu A; Yu C; Qiu C; Wu Q; Huang C; Li X; She X; Wan K; Liu L; Li M; Wang Z; Chen Y; Hu F; Song D; Li K; Zhao C; Deng H; Sun X; Xu F; Lai S; Luo X; Hu J; Wang G
    Oncogene; 2023 May; 42(19):1572-1584. PubMed ID: 36991117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of PELATON links to the INHBA gene in the TGF-β pathway in colorectal cancer using a combination of bioinformatics and experimental investigations.
    Abutalebi M; Li D; Ahmad W; Mokhtari K; Entezari M; Hashemi M; Fu J; Maghsoudloo M
    Int J Biol Macromol; 2024 Jun; 270(Pt 1):132239. PubMed ID: 38735606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.